|66.51||+1.38||+2.12%||Vol 679.29K||1Y Perf 98.16%|
|Sep 15th, 2021 16:00 DELAYED|
|- -%||- -|
|Target Price||108.33||Analyst Rating||Strong Buy 1.00|
|Potential %||62.88||Finscreener Ranking||★★★★★ 64.31|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★+ 59.00|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 63.42|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||52.10||Earnings Rating||Sell|
|Market Cap||3.50B||Earnings Date||4th Nov 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|5 Years||1 538.18%|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th Nov 2021|
|Estimated EPS Next Report||-0.14|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||548.65K|
|Avg. Monthly Volume||475.24K|
|Avg. Quarterly Volume||504.48K|
CareDx Inc. (NASDAQ: CDNA) stock closed at 66.51 per share at the end of the most recent trading day (a 2.12% change compared to the prior day closing price) with a volume of 782.67K shares and market capitalization of 3.50B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 475 people. CareDx Inc. CEO is Reginald Seeto.
The one-year performance of CareDx Inc. stock is 98.16%, while year-to-date (YTD) performance is -8.2%. CDNA stock has a five-year performance of 1538.18%. Its 52-week range is between 30.27 and 99.83, which gives CDNA stock a 52-week price range ratio of 52.10%
CareDx Inc. currently has a PE ratio of -385.90, a price-to-book (PB) ratio of 7.62, a price-to-sale (PS) ratio of 13.29, a price to cashflow ratio of 1 429.20, a PEG ratio of 2.32, a ROA of -1.94%, a ROC of -2.29% and a ROE of -2.37%. The company’s profit margin is -3.34%, its EBITDA margin is -0.40%, and its revenue ttm is $253.60 Million , which makes it $4.82 revenue per share.
Of the last four earnings reports from CareDx Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.14 for the next earnings report. CareDx Inc.’s next earnings report date is 04th Nov 2021.
The consensus rating of Wall Street analysts for CareDx Inc. is Strong Buy (1), with a target price of $108.33, which is +62.88% compared to the current price. The earnings rating for CareDx Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CareDx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
CareDx Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.02, ATR14 : 3.57, CCI20 : -135.42, Chaikin Money Flow : 0.02, MACD : -3.19, Money Flow Index : 23.42, ROC : -16.69, RSI : 36.12, STOCH (14,3) : 19.33, STOCH RSI : 0.48, UO : 35.84, Williams %R : -80.67), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CareDx Inc. in the last 12-months were: Fred E. Cohen (Option Excercise at a value of $306 005), George W. Bickerstaff (Sold 20 000 shares of value $1 348 391 ), Michael Brian Bell (Option Excercise at a value of $429 549), Michael Brian Bell (Sold 32 574 shares of value $1 568 487 ), Michael D. Goldberg (Sold 0 shares of value $0 ), Michael D. Goldberg (Sold 94 525 shares of value $6 439 253 ), Peter Maag (Option Excercise at a value of $3 270 523), Peter Maag (Sold 367 405 shares of value $23 384 568 ), Ralph Snyderman (Sold 21 500 shares of value $1 828 362 ), Reginald Seeto (Option Excercise at a value of $1 633 307), Reginald Seeto (Sold 69 338 shares of value $6 124 915 ), Sasha King (Option Excercise at a value of $869 024), Sasha King (Sold 122 806 shares of value $7 793 348 ), William A. Hagstrom (Sold 0 shares of value $-89 750 ), William A. Hagstrom (Sold 15 000 shares of value $986 594 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.